Hidetaka Ushigome

982 total citations
69 papers, 683 citations indexed

About

Hidetaka Ushigome is a scholar working on Transplantation, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hidetaka Ushigome has authored 69 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Transplantation, 22 papers in Nephrology and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hidetaka Ushigome's work include Renal Transplantation Outcomes and Treatments (25 papers), Blood Pressure and Hypertension Studies (20 papers) and Cardiovascular Health and Disease Prevention (17 papers). Hidetaka Ushigome is often cited by papers focused on Renal Transplantation Outcomes and Treatments (25 papers), Blood Pressure and Hypertension Studies (20 papers) and Cardiovascular Health and Disease Prevention (17 papers). Hidetaka Ushigome collaborates with scholars based in Japan, United States and Greece. Hidetaka Ushigome's co-authors include Norio Yoshimura, Masahiko Okamoto, Kiyokazu Akioka, Shuji Nobori, Tsukasa Nakamura, Satoshi Kaihara, Y Kadotani, Tomoyuki Suzuki, Koichi Kozaki and Rikio Yoshimura and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Transplantation.

In The Last Decade

Hidetaka Ushigome

64 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetaka Ushigome Japan 15 203 193 177 175 152 69 683
Dag Olav Dahle Norway 17 239 1.2× 127 0.7× 215 1.2× 244 1.4× 280 1.8× 37 811
Alberto Martínez Castelao Spain 12 252 1.2× 128 0.7× 317 1.8× 93 0.5× 152 1.0× 46 616
J.G Cotorruelo Spain 15 294 1.4× 157 0.8× 481 2.7× 193 1.1× 188 1.2× 50 762
H. A. Bock Switzerland 15 161 0.8× 64 0.3× 160 0.9× 103 0.6× 237 1.6× 28 748
Paul Trevillian Australia 13 111 0.5× 62 0.3× 152 0.9× 82 0.5× 125 0.8× 48 514
Lynne Newton United States 11 324 1.6× 93 0.5× 440 2.5× 144 0.8× 202 1.3× 12 956
R. Brunkhorst Germany 17 110 0.5× 79 0.4× 85 0.5× 147 0.8× 317 2.1× 35 885
Daniel Casanova Spain 14 360 1.8× 117 0.6× 83 0.5× 81 0.5× 80 0.5× 53 701
Tadashi Sofue Japan 12 89 0.4× 59 0.3× 82 0.5× 113 0.6× 328 2.2× 52 540
María Dolores Checa Spain 10 168 0.8× 52 0.3× 267 1.5× 76 0.4× 203 1.3× 14 553

Countries citing papers authored by Hidetaka Ushigome

Since Specialization
Citations

This map shows the geographic impact of Hidetaka Ushigome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Ushigome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Ushigome more than expected).

Fields of papers citing papers by Hidetaka Ushigome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetaka Ushigome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Ushigome. The network helps show where Hidetaka Ushigome may publish in the future.

Co-authorship network of co-authors of Hidetaka Ushigome

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetaka Ushigome. A scholar is included among the top collaborators of Hidetaka Ushigome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetaka Ushigome. Hidetaka Ushigome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ushigome, Emi, Takashi Yoshimura, Toru Tanaka, et al.. (2023). Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study. Hypertension Research. 46(3). 565–574. 7 indexed citations
2.
Nakamura, Tsukasa, et al.. (2022). Intra-Liver Allograft C3d-Binding Donor-Specific Anti-HLA Antibodies Predict Rejection After Liver Transplantation. Transplantation Proceedings. 54(2). 450–453. 2 indexed citations
3.
Nakamura, Tsukasa, et al.. (2022). Single vs Multiple Arterial Reconstructions in Living Donor Liver Transplant. Transplantation Proceedings. 54(2). 399–402.
4.
Nakamura, Tsukasa, et al.. (2022). Impact of Donor and Recipient Age on Outcomes After Living Donor Liver Transplant. Transplantation Proceedings. 54(2). 438–442. 12 indexed citations
5.
Zen, Kan, Tsukasa Nakamura, Hidetaka Ushigome, et al.. (2020). Successful Endovascular Treatment for Very-Late-Onset and Acute Progressive Multiple Transplant Renal Segmental Artery Stenoses: A Case Report. Transplantation Proceedings. 53(4). 1262–1267.
6.
Okamura, Takuro, Emi Ushigome, Toru Tanaka, et al.. (2019). Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA‐HBP study. Journal of Diabetes Investigation. 10(6). 1543–1549. 7 indexed citations
7.
Nakamura, Tsukasa, et al.. (2019). Detection of Intragraft Anti-Blood Group A and B Antibodies Following Renal Transplantation. Transplantation Proceedings. 51(5). 1371–1377. 3 indexed citations
8.
Ushigome, Emi, Toru Tanaka, Goji Hasegawa, et al.. (2019). Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study. Diabetes Research and Clinical Practice. 158. 107920–107920. 8 indexed citations
9.
Nakamura, Tsukasa, Taku Iida, Hidetaka Ushigome, et al.. (2017). Risk Factors and Management for Biliary Complications Following Adult Living-Donor Liver Transplantation. Annals of Transplantation. 22. 671–676. 16 indexed citations
10.
Fukushima, Keizo, et al.. (2013). Dose Adjustment Strategy of Cyclosporine A in Renal Transplant Patients: Evaluation of Anthropometric Parameters for Dose Adjustment and C0 vs. C2 Monitoring in Japan, 2001-2010. International Journal of Medical Sciences. 10(12). 1665–1673. 7 indexed citations
11.
Okamoto, Masahiko, Tomoyuki Suzuki, Masato Fujiki, et al.. (2010). The Consequences for Live Kidney Donors With Preexisting Glucose Intolerance Without Diabetic Complication: Analysis at a Single Japanese Center. Transplantation. 89(11). 1391–1395. 29 indexed citations
12.
Yoshimura, Norio, Hideaki Okajima, Hidetaka Ushigome, et al.. (2010). Current status of organ transplantation in Japan and worldwide. Surgery Today. 40(6). 514–525. 24 indexed citations
13.
Okamoto, Masahiko, Kiyokazu Akioka, Shuji Nobori, et al.. (2009). Short- and Long-Term Donor Outcomes After Kidney Donation: Analysis of 601 Cases Over a 35-Year Period at Japanese Single Center. Transplantation. 87(3). 419–423. 83 indexed citations
14.
Okamoto, Masahiko, Tomoyuki Suzuki, Shuji Nobori, et al.. (2009). Histopathologic evaluation of living kidney donor candidates by pre‐operative kidney biopsy. Clinical Transplantation. 23(s20). 58–61. 4 indexed citations
15.
Ushigome, Hidetaka, Tomoyuki Suzuki, Atsushi Yoshizawa, et al.. (2008). Successful treatment of de novo thrombotic microangiopathy after minor ABO‐mismatched living donor kidney transplantation. Clinical Transplantation. 22(s19). 25–30. 1 indexed citations
16.
Kadotani, Y, et al.. (2003). アンチセンスTissue factor(TF)でのラット腎虚血再潅流障害の制御. 21(4). 163. 1 indexed citations
17.
Matsuyama, Masahide, Rikio Yoshimura, Kiyokazu Akioka, et al.. (2003). Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation. 76(5). 786–791. 45 indexed citations
18.
Okamoto, Masahiko, Shuji Nobori, Atsushi Higuchi, et al.. (2003). Clinicopathological evaluation of renal allografts of four patients by 20‐year protocol biopsies. Clinical Transplantation. 17(s10). 20–24. 2 indexed citations
19.
Ushigome, Hidetaka, Hajime Sano, Masahiko Okamoto, et al.. (2002). The Role of Tissue Factor in Renal Ischemic Reperfusion Injury of the Rat. Journal of Surgical Research. 102(2). 102–109. 23 indexed citations
20.
Nakamura, Kenji, Y Kadotani, Hidetaka Ushigome, et al.. (2002). Antisense oligonucleotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochemical and Biophysical Research Communications. 297(3). 433–441. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dag Olav Dahle Breakdown of academic impact, for papers by Alberto Martínez Castelao Breakdown of academic impact, for papers by J.G Cotorruelo Breakdown of academic impact, for papers by H. A. Bock Breakdown of academic impact, for papers by Paul Trevillian Breakdown of academic impact, for papers by Lynne Newton Breakdown of academic impact, for papers by R. Brunkhorst Breakdown of academic impact, for papers by Daniel Casanova Breakdown of academic impact, for papers by Tadashi Sofue Breakdown of academic impact, for papers by María Dolores Checa
Rankless by CCL
2026